-
Lundquist Institute Investigator Eiji Yoshihara, PhD., Receives Two Major Grants for Diabetes Research
TRDRP Research grant and JDRF multi-PI grant will help to establish the basis of diabetes and provides new therapeutics
Research -
Dr. Michael Yeaman Awarded $11.5 Million NIAID/HHS Grant for Research To Understand and Solve Persistent Bloodstream Infections
The research will apply state-of-the-art science to address antibiotic-resistant bloodstream infections caused by Staphylococcus aureus (MRSA) and Candida albicans
Research -
The Lundquist Institute Receives Gift from the Samberg Foundation to Study the Use of Psilocybin in Alleviating Demoralization and Psychological Distress in Palliative Care
The gift will facilitate an FDA-approved multi-site clinical trial under the co-direction of Lundquist Investigators, Dr. Charles S. Grob and Dr. Anthony P. Bossis
Research -
Lundquist Institute Investigator Dr. Virender Rehan and Advent Therapeutics Awarded $3 Million NIH Small Business Innovation Research Grant for Life-saving Premature Infant Research
The NIH Award will Support Dr. Rehan’s and Advent’s Research to Develop and Position Its Novel Aerosolized Vitamin A Formulation for Commercialization to Prevent BPD
Research -
Institute for Translational Genomics and Population Sciences Contributes to New Study Published in Nature Genetics
DNA Discovery Sheds Light on How Humans Maintain Healthy Blood Sugar Levels After Meals and How the Process Goes Wrong in Type 2 Diabetes
Research -
Lundquist Institute Investigators Co-Author Paper in JAMA on Coronary Heart Disease (CHD) Risk Prediction
DNA Discovery Sheds Light on How Humans Maintain Healthy Blood Sugar Levels After Meals and How the Process Goes Wrong in Type 2 Diabetes
Research -
Lundquist Institute Start-Up Vitalex Biosciences Awarded Grant from NIAID/NIH
Award is for the VX-01 monoclonal antibody (mAb) program targeting the debilitating indication of mucormycosis
Research -
Lundquist Institute’s Dr. Eric Daar Lead Author in Paper in the Annals of Internal Medicine
The study showed that antibody combination provides strong protection against severe COVID-19 in large international trial. The trial enrolled non-hospitalized patients with early, mild to moderate…
Research -
The Lundquist Institute Now Working on a Vaccine for the Urgent Fungal Threat of Candida Auris
CDC says Candida auris is spreading at an alarming rate throughout health care facilities in the U.S. and is resistant to several antifungal drugs
Research -
2022 Lundquist Legends Scott Filler, MD, and Darrell Harrington, MD, Honored for Their Outstanding Career Achievements
Dr. Filler feted for his research on fungal infections and vaccines while Dr. Harrington celebrated for his work in internal medicine and treating venous thromboembolism (VTE)
Research